Leerink Swann Downgrades Auxilium Pharmaceuticals (AUXL) to Market Perform on Valuation; Outlook Mixed
Tweet Send to a Friend
Leerink Swann downgraded Auxilium Pharmaceuticals (NASDAQ: AUXL) from Outperform to Market Perform with a price target of $27.00 (from $25.00).
This article: 128 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This article: 128 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
